Targeting colorectal carcinogenesis using a cinnamon-derived food factor
使用肉桂源性食物因子对抗结直肠癌
基本信息
- 批准号:8442671
- 负责人:
- 金额:$ 19.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntioxidantsBiochemical GeneticsCellsChemicalsChemopreventionChemopreventive AgentCinnamomum cassiaCinnamon - dietaryClinical ResearchColitisColonColorectalColorectal CancerConsumptionCytoprotectionDataDevelopmentDiabetic NephropathyDietary FactorsDimensionsDiseaseDocumentationDoseEpithelialEpithelial CellsFDA approvedFlavoringFoodFood AdditivesFutureHealthHumanIncidenceInflammationInflammatoryInterventionKnockout MiceLesionModelingMolecularMolecular TargetMorbidity - disease rateMusNatureNuclearOralOral AdministrationOxidation-ReductionPowder dose formPredispositionProteinsProteomicsPublishingResearchResearch Project GrantsRoleSafetySkinSpicesSri LankaStagingStructure-Activity RelationshipTestingTimeVolatile Oilsbasebiological adaptation to stresscancer chemopreventioncarcinogenesiscinnamic aldehydedesignmetastatic colorectalmortalityoutcome forecastpreclinical studyprototypepublic health relevanceresponsetooltranscription factortumor
项目摘要
DESCRIPTION (provided by applicant): Colorectal cancer (CRC) is a major cause of tumor-related morbidity and mortality worldwide. Recent research strongly suggests that the redox-sensitive transcription factor Nrf2 (nuclear factor-E2-related factor 2) is a promising molecular target for chemoprevention of inflammation-driven colorectal carcinogenesis. The ground bark of Cinnamomum aromaticum (cassia) and Cinnamomum verum (Ceylon cinnamon), commonly referred to as 'cinnamon', is one of the three most consumed spices in the world, yet health effects of cinnamon consumption have remained mostly unexplored at the molecular level. Recently, we have identified the cinnamon-derived food factor cinnamaldehyde as the key principle in cinnamon powder responsible for potent induction of the Nrf2-regulated antioxidant response in human colon cells, conferring cytoprotection against subsequent oxidative and genotoxic insult. We propose exploratory research that tests the overall hypothesis that cinnamaldehyde represents a potent chemopreventive dietary factor targeting colorectal carcinogenesis through modulation of Nrf2-orchestrated cytoprotective mechanisms. To test this hypothesis, the following specific aims will be pursued: Aim #1. To define the specific molecular targets involved in Nrf2-activation by cinnamaldehyde in colorectal epithelial cells. Aim #2. To test feasibility of cinnamaldehyde-based intervention targeting colorectal carcinogenesis in an accepted murine model and to determine mechanistic involvement of Nrf2 in cinnamaldehyde chemopreventive activity. Successful completion of this project will generate critical proof-of-principle data guiding the rational design of future preclinical and clinical studies that aim at developing cinnamaldehyde for chemopreventive intervention targeting human colorectal carcinogenesis.
描述(由申请人提供):结直肠癌(CRC)是全球肿瘤相关发病率和死亡率的主要原因。最近的研究强烈表明,氧化还原敏感性转录因子Nrf 2(核因子E2相关因子2)是化学预防炎症驱动的结直肠癌发生的一个有前途的分子靶点。肉桂(Cinnamomum aromaticum)和锡兰肉桂(Cinnamomum verum)的地面树皮,通常被称为“肉桂”,是世界上三种消费量最大的香料之一,但肉桂消费对健康的影响在分子水平上仍未被探索。最近,我们已经确定了肉桂衍生的食物因子肉桂醛的关键原则,肉桂粉负责有效诱导Nrf2调节的抗氧化反应在人类结肠细胞,赋予细胞保护,防止随后的氧化和遗传毒性的侮辱。我们提出了探索性研究,测试的总体假设,肉桂醛是一种有效的化学预防饮食因子,通过调节Nrf2协调的细胞保护机制,靶向结直肠癌的发生。为了检验这一假设,将追求以下具体目标:目标1。明确肉桂醛激活结直肠上皮细胞Nrf2的特异性分子靶点。目标2。在公认的小鼠模型中测试以肉桂醛为基础的干预靶向结直肠癌发生的可行性,并确定Nrf2参与肉桂醛化学预防活性的机制。该项目的成功完成将产生关键的原理验证数据,指导未来临床前和临床研究的合理设计,旨在开发肉桂醛用于针对人类结直肠癌发生的化学预防干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georg T Wondrak其他文献
GLO1 Downregulation in Human Renal Cell Carcinoma Enables Targeted Chemotherapeutic Intervention Using Methylglyoxal as Cytotoxic Heat Shock Inducer
- DOI:
10.1016/j.freeradbiomed.2010.10.184 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Christopher M Cabello;Shuxi Qiao;Warner B Bair;Angela L Davis;Jessica L Lesson;Georg T Wondrak - 通讯作者:
Georg T Wondrak
218 - Repurposing the Electron Transfer Reactant PMS (Phenazine Methosulfate) as an Experimental Redox Chemotherapeutic for the Superoxide-Dependent Apoptotic Elimination of Malignant Cells
- DOI:
10.1016/j.freeradbiomed.2015.10.262 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Anh B Hua;Sophia L Park;Rebecca Justiniano;Mohammad Fazel;Christopher M Cabello;Georg T Wondrak - 通讯作者:
Georg T Wondrak
326 - Acute Solar UV Exposure Generates Photodamage-Associated Protein Epitopes in Healthy Human Skin: Implications for Cutaneous Tumorigenesis
- DOI:
10.1016/j.freeradbiomed.2014.10.223 - 发表时间:
2014-11-01 - 期刊:
- 影响因子:
- 作者:
Joshua D Williams;Yira Bermudez;Fangru Lian;Koji Uchida;Sophia L Park;Georg T Wondrak - 通讯作者:
Georg T Wondrak
144 - The Clinical Antimalarial Mefloquine Induces Lethal ER and Oxidative Stress Targeting BRAF-Kinase Inhibitor-Resistant Malignant Melanoma Cells
- DOI:
10.1016/j.freeradbiomed.2015.10.185 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Sophia L Park;Tamara Steinfass;Georg T Wondrak - 通讯作者:
Georg T Wondrak
251 - The Endogenous Tryptophan-Derived Photoproduct and AhR Agonist 6-Formylindolo[3,2-B]carbazole (FICZ) Is a Nanomolar Cutaneous Photosensitizer That Can Be Harnessed for the Oxidative Elimination of Skin Cancer Cells in Vitro and in Vivo
- DOI:
10.1016/j.freeradbiomed.2015.10.298 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Rebecca Justiniano;Sophia L Park;Joshua D Williams;Daniel R Wieland;Georg T Wondrak - 通讯作者:
Georg T Wondrak
Georg T Wondrak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georg T Wondrak', 18)}}的其他基金
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
重新利用临床 ACT 抗疟药进行实验性黑色素瘤干预
- 批准号:
10549763 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
重新利用临床 ACT 抗疟药进行实验性黑色素瘤干预
- 批准号:
10093984 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
项目 1:TLR4 作为预防皮肤癌的新靶点
- 批准号:
10475132 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
重新利用临床 ACT 抗疟药进行实验性黑色素瘤干预
- 批准号:
10333277 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
项目 1:TLR4 作为预防皮肤癌的新靶点
- 批准号:
10686367 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
项目 1:TLR4 作为预防皮肤癌的新靶点
- 批准号:
10252869 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
项目 1:TLR4 作为预防皮肤癌的新靶点
- 批准号:
10015216 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Exploring the role of HOCI in skin photodamage, immunosuppression, and carcinogenesis
探索 HOCI 在皮肤光损伤、免疫抑制和癌变中的作用
- 批准号:
9904653 - 财政年份:2019
- 资助金额:
$ 19.77万 - 项目类别:
Targeting colorectal carcinogenesis using a cinnamon-derived food factor
使用肉桂源性食物因子对抗结直肠癌
- 批准号:
8598464 - 财政年份:2013
- 资助金额:
$ 19.77万 - 项目类别:
Testing feasibility of artemisinin-based synthetic-lethal suppression of skin pho
测试基于青蒿素的皮肤光合成致死抑制的可行性
- 批准号:
8450745 - 财政年份:2012
- 资助金额:
$ 19.77万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 19.77万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 19.77万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 19.77万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 19.77万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 19.77万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 19.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)